Elicio Therapeutics, Inc. (ELTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$55.27M2021: -$39.31M2022: -$23.73M2023: -$35.74M2024: -$44.99M2025: -$37.71M-$37.71M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$37.71M+16.2%
2024-$44.99M-25.9%
2023-$35.74M-50.6%
2022-$23.73M+39.6%
2021-$39.31M+28.9%
2020-$55.27M